Open AccessPRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Author(s) -
Hiroaki Matsubara,
Takahiro Fukuda,
Yuichiro Awazu,
Shigenori Nanno,
Masahiro Shimomura,
Yuta Inoue,
M. Yamauchi,
Toshihiro Yasui,
Toshiyuki Sumi
Publication year - 2020
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2020.12423
Subject(s) - carboplatin , cisplatin , cancer research , chemotherapy , molecular medicine , ovarian cancer , oncogene , biology , serous fluid , debulking , oncology , apoptosis , ovarian carcinoma , cancer , cell cycle , medicine , biochemistry